While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Cross-industry collaboration is key to fighting rising costs for consumers. The Fast Company Impact Council is a private ...
A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...
A federal judge in Missouri rejected three major pharmacy benefit managers’ push to pause the Federal Trade Commission’s ...
Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
More than 7,500 students with Type 1 diabetes enter college every year, and the number is only growing. At the University of ...
The settlement filed in Newark, N.J. federal court comes after similar settlements with Eli Lilly and Sanofi last year. It ...
Over the past decade, the rising cost of insulin epitomized the broader systemic issue of higher healthcare out-of-pocket costs that prevented many Americans from accessing essential care.